Is Merck & Co. Stock Worth Buying Before the End of 2022?

Published on November 29, 2022

Healthcare company Merck & Co. (MRK) is set to acquire Imago BioSciences (IMGO) for more than $1 billion. The stock has gained more than 40% this year. However, given the...